[ad_1]
As Nike shares on Friday headed toward their biggest drop ever following the sneaker maker’s pessimistic outlook a day earlier, Wall Street analysts were retrenching — with some even questioning the company’s management.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...